WO2013182000A1 - Disposable sterile injector for retaining microparticles - Google Patents

Disposable sterile injector for retaining microparticles Download PDF

Info

Publication number
WO2013182000A1
WO2013182000A1 PCT/CN2013/076271 CN2013076271W WO2013182000A1 WO 2013182000 A1 WO2013182000 A1 WO 2013182000A1 CN 2013076271 W CN2013076271 W CN 2013076271W WO 2013182000 A1 WO2013182000 A1 WO 2013182000A1
Authority
WO
WIPO (PCT)
Prior art keywords
outer cylinder
syringe
filter
membrane
particles
Prior art date
Application number
PCT/CN2013/076271
Other languages
French (fr)
Chinese (zh)
Inventor
杨昌燕
陈志成
周培聪
Li SUN (孙丽)
Original Assignee
广州均和纳米新材料科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州均和纳米新材料科技有限公司 filed Critical 广州均和纳米新材料科技有限公司
Publication of WO2013182000A1 publication Critical patent/WO2013182000A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3145Filters incorporated in syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M2005/342Off-center needles, i.e. needle connections not being coaxial with the longitudinal symmetry axis of syringe barrel

Definitions

  • the invention belongs to the field of medical devices, and relates to a syringe, in particular to a disposable sterile particle trapping syringe.
  • Infusion therapy is an important treatment, especially intravenous infusion and intravenous injection. Because the drug directly enters the blood circulation system, its efficacy is rapidly used. However, in recent years, the harm caused by the injection of foreign bodies and particulates in infusions has caused widespread concern, and it has become urgent to solve the problem of particulate contamination.
  • Intravenous drip and intravenous injection microparticles are unintentionally added to the swimming, insoluble exogenous substances and soluble and undissolved drugs, insoluble particles including rubber particles, polyester flakes, thin chips, color points Inorganic salts, insoluble inorganic salts, activated carbon microparticles, fibers, and chemical particles produced by improper combination of drugs, if these particles are mixed into the infusion, clinical application may cause an infusion reaction, which may lead to acute reactions or long-term potential risks. For example, a large amount of particles injected into the human body may cause serious damage to the body.
  • the latent period of the particles in the body can be metabolized for decades, and the larger particles are blocked by the blood circulation in the small blood vessels, causing different degrees of tissue necrosis and damage, such as Phlebitis, pulmonary granuloma, thrombosis and vascular embolism, induce tumor formation, etc., and even endanger the patient's life.
  • tissue necrosis and damage such as Phlebitis, pulmonary granuloma, thrombosis and vascular embolism, induce tumor formation, etc., and even endanger the patient's life.
  • the Pharmacopoeia of China stipulates that no more than 10 insoluble particles with a particle size > ⁇ ⁇ ⁇ ⁇ (millimeters) per ml of infusion.
  • the sources of particles in the liquid may be the following:
  • Needle puncture bottle stopper Dissolve the cuttings under the drug.
  • the plastic needle of the infusion device can also increase the amount of particles in the liquid by 1. 6 ⁇ 27. 6 times when inserting the liquid bottle rubber plug.
  • the main way to eliminate particulate contamination in the infusion is to add a microfilter to filter the solution before it enters the body.
  • researchers have installed a filter device with a filter on the infusion set.
  • the filter device is installed at the end of the infusion set (the lower end of the drip bucket).
  • the filtration principle is realized by the negative pressure generated by the liquid sinking in the bottle. filter.
  • Adding a filter device at this stage does solve some of the particulate contamination problems, but the price of the infusion set with the filter device is significantly increased, which increases the burden on the patient; on the other hand, the filter pack After the infusion set is filtered, 500 ⁇ 1500ml of liquid is filtered, and as the particles accumulate, there is also a phenomenon that the membrane pores of the filter device are clogged, affecting the initial flow rate, and the filtration rate is attenuated, so that the infusion set cannot be normally infused.
  • the disposable sterile particle trapping syringe of the invention comprises an outer cylinder, a push rod placed in the outer cylinder and a needle seat for loading the needle on the front end side of the outer cylinder, and the outer cylinder and the needle seat are connected by the liquid outlet, A filtering device is disposed, the filtering device is provided with a filtering membrane attached to the liquid outlet, and is closed to the front end and opened to the rear end.
  • the filter device is embedded in the topmost front wall of the outer cylinder.
  • the filter device includes an insert, and a filter membrane is fixed in the insert.
  • the top end front wall of the outer cylinder is disposed on the side of the needle seat along an arc of the outer cylinder to form an assembly long hole matching the insert. Inside the long hole.
  • the insert comprises a pin head, a connecting piece and a hollow membrane ring which are integrally connected in series, the filter membrane being fixed on the membrane ring, the connecting piece and the membrane ring being inside the outer cylinder, and the pin head being outside the outer cylinder.
  • the filter membrane is fixed between a top cover and a lower cover of a pair of buckles to form a membrane, and the filter membrane is assembled in the form of the membrane.
  • the upper cover and the lower cover are ring bodies, and the hollow portion of the ring body is provided with a mesh for lining the filter film, and the solid portions of the upper cover and the lower cover are respectively provided with indented fixed protrusions and protrusions.
  • the positioning of the positioning groove is larger than the size of the diaphragm edge 0. 05 leg.
  • the outermost front wall of the outer cylinder is thickened to 4 mm.
  • the front end of the outer cylinder is a semi-conical force-receiving side wall thickened to 2 mm on the side where the diaphragm is mounted.
  • the insertion of the thickness of the upper cover is 0. 05 ⁇
  • the thickness of the lower cover is 0. 05 mm
  • the thickness of the filter film is 0. 11-0.
  • the thickness of the pin head is 12 mm
  • the thickness of the connecting piece is 0.332 mm
  • the thickness of the film ring is 0. 35 mm
  • the length of the arc of the pin head is larger than the length of the arc of the long hole of the outer tube assembly.
  • the single-use sterile trapping syringe of the present invention can temporarily remove the particles in the injection liquid, and absolutely control the particles in the ejection liquid to no longer generate 45 ⁇ or more, and the syringe with the trapping liquid can directly push the muscles. Note that injection safety is guaranteed.
  • the filter device at the end of the infusion device only needs to block the infusion of the infusion device. Particles, which will reduce the blockage of the filter device at the end of the infusion set, the attenuation of the filtration rate, and the occurrence of initial flow.
  • Disposable sterile microparticle-retaining syringe presents a sandwich-embedded filter device.
  • the diaphragm is statically closed, the suction is self-opening, and the pusher is self-closing. At the same time, the liquid must be forced through the membrane channel to effectively block the particles.
  • the design of the structure is only on the top of a conventional and ordinary syringe, with a thickened interlayer embedded with a circular single-sided hanging filter device, which can open and close with the liquid microfluid and realize the pumping of the solvent. Suck, do whatever you want.
  • Figure 1 is a schematic view showing the structure of a single-use sterile particle trapping syringe of the present invention
  • Figure 2 is a schematic view showing the structure of a diaphragm in a disposable sterile microparticle-retaining syringe of the present invention
  • Figure 3 is a structural view of a filtering device in a single-use sterile microparticle-retaining syringe of the present invention
  • Figure 4 is a cross-sectional view showing the front end structure of the outer cylinder 3 in a disposable sterile particle-retaining syringe of the present invention
  • Figure 5 is a left side view of Figure 4 (outer tube part);
  • Figure 6 is an assembled view of the filter device 6 in the disposable sterile particle trapping syringe of the present invention
  • Figure 7 is a structural view of the front end of the syringe outer tube after the assembly of Figure 6 is completed
  • Fig. 8 is a view showing a state of change of the diaphragm 1 in the filtering device 6 when the disposable sterile particle trapping syringe of the present invention is used, wherein the A frame is in a state of being sucked, the B frame is in a liquid absorption state, and the C frame is a liquid pushing state, D The frame is in the state of completion of injection.
  • the invention provides a disposable sterile particle trapping syringe, which is modified for the existing structure syringe, and a filtering device is added at the top end thereof to achieve the purpose of intercepting and ensuring safe injection of the particles in the liquid medicine during the injection.
  • the present invention provides a single-use sterile particle trapping syringe, which comprises an outer cylinder 3 of a conventional ordinary syringe, a push rod 4 placed in the outer cylinder, and a front end side of the outer cylinder for needle loading.
  • the needle holder 5, which is characterized by the present invention, further comprises a filtering device 6 which is embedded in the innermost wall of the outermost end of the outer cylinder 3 and which faces the position of the liquid outlet of the needle holder 5.
  • the filter unit 6 consists of a diaphragm 1 and an insert 2, as shown in Fig. 3. among them:
  • the diaphragm 1 is sequentially pressed by the upper cover 11, the filter membrane 12 and the lower cover 13 to form an elliptical sheet-like body, and the upper cover 11 and the lower cover 13 are filter holders, and are formed in a ring shape.
  • the hollow portion of the ring body is provided with a mesh 14 for lining the filter film 12, and the solid portions of the upper cover 11 and the lower cover 13 are respectively provided with indented fixed protrusions and protrusions, and the filter film 12 is a sheet body.
  • the upper cover 11 and the lower cover 13 are pressed by the indentations and the protrusions, and then the hot film is pressed, and the filter film 12 is pressed between the upper and lower covers.
  • the upper cover 13 is made of a polypropylene material, and has a thickness of 0.15 legs; the lower cover 13 is made of PP material, and has a thickness of 0.05 mm ; the filter film 12 can be made of a polyethersulfone film (aperture 0). 45 ⁇ ⁇ ), thickness 00. 1 1-0. 12mm.
  • the insert 2 is integrally formed in a sheet shape, and includes a pin head 21, a connecting piece 22 and a membrane ring 23 which are integrally connected in series, and is shaped like a rivet.
  • the outer edge of the pin head 21 is curved, the inner connecting piece 22 is connected, and the connecting piece is connected.
  • an open loop is formed to form a diaphragm 23 for mounting the diaphragm 1.
  • the insert 2 is integrally made of PP material, the pin head 21 is 12 mm thick, the connecting piece 22 is thick 0. 2 mm, the film ring thickness is 0. 35 mm, and the insert 2 is 15 mm overall.
  • the diaphragm 1 is placed at the position of the diaphragm 23 of the insert 2, and fixed by a heat press to form a filter unit 6 (see Fig. 3). It is apparent that the size of the filter membrane 12 and the membrane ring 23 in the filter unit should match the size of the syringe (11 specifications in specifications lml to 100 ml).
  • Adjustments include: a) The top outlet of the syringe is calculated from the center line and displaced 3 mm to the center axis of the syringe;
  • the front wall 31 of the top end of the syringe barrel 3 is thickened (see Figures 4 and 5) and can be generally thickened to 4 mm for the purpose of placing the top of the syringe barrel 3
  • the wall is thickened by the original thinner (1.5 legs) ("thickening" concept) to facilitate the opening design of the following three);
  • an elongated hole 32 is opened along the arc of the outer cylinder (for example, a hole thickness of 0.35 legs and an arc length of 20 legs) is used for The filter device 6 is inserted, and the arc length (20 mm) of the assembly long hole 32 is smaller than the arc length of the pin head 21 (the pin head thickness is 36 mm, the length is 2 101111) to position the filter device 6; and the front wall 31 of the outer tube 3
  • the inner side is disposed with the positioning hole 33 at a position where the long hole 32 is to be assembled (the
  • the side wall of the outer tube 3 on the side on which the long hole 32 is formed needs to be thickened in such a manner that the side wall of the outer tube 3 forms a semi-conical force-receiving side wall 34 ( Referring to Fig. 5, the thickness is 2 mm X width 15 mm X length 20 mm), the thickened reinforcing force side wall 34 can ensure that the outer tube 3 has sufficient strength and load when the filter device 6 is inserted into the assembled long hole 32 of the front wall 31 of the outer cylinder 3. Force ("strengthening" concept).
  • the above-mentioned one to four) adjusted thickening reinforced single-side slotted syringe outer cylinder 3 is integrally molded.
  • the diaphragm 1 of the filtering device is directed toward the syringe outer cylinder 3, inserted into the front wall 31 from the fitting long hole 32 into the positioning recess 33 (see Fig. 6), and the pin head 21 of the insert 2 is caught in the fitting long hole 32.
  • External fixation (“hanging” concept), see Figure 7, shows the structure of the front end of the outer cylinder of the syringe after assembly, and the assembly is used to obtain a one-time use of a thickened and reinforced laminated embedded circular one-side filter device.
  • Sterile particle trapping syringe see Figure 1, the needle is attached to the needle hub 5).
  • the A-frame shows that the disposable sterile particle-retaining syringe has been air-drawn, and the syringe push-pull rod 4 is at the foremost end of the syringe, and is ready to be sucked. At this time, the diaphragm 1 is located in the groove and is in a closed state;
  • B-frame shows the single-use sterile microparticle-retaining syringe to perform the pumping action.
  • the syringe push-pull rod 4 is pulled back, the liquid medicine enters from the liquid-suction hole, and the diaphragm 1 is pushed back into the syringe barrel. At this time, the diaphragm 1 Is turned on;
  • the C-frame shows a one-time use of a sterile microparticle-retaining syringe to perform a pushing action, and the syringe push-pull rod 4 is pushed forward, and the hydraulically-driven diaphragm 1 is closed from the open state to the forward state, and the liquid medicine is pushed out through the aperture of the diaphragm 1;
  • the D-frame shows the completion of the single-use sterile microparticle-retaining syringe pusher, at which point the syringe push-pull rod 4 is pushed to the foremost end of the syringe, the diaphragm 1 is located in the groove, and is closed, and the liquid medicine has passed through the diaphragm 1 The pores are pushed out, and the particles present in the liquid are intercepted by the membrane 1 and remain in the syringe.
  • the diaphragm can effectively intercept the particles and ensure the input into the human body. There are no particles in the liquid, which eliminates particulate contamination that seriously plagues the safety of the infusion.
  • the filter holder (upper cover and lower cover) is made of PP material, does not contain bisphenol A substance, and its safety is fully in line with EU standards, and has the advantages of not easy to be broken and stable. Even in the case of high temperature heating, no harmful substances are released; the filter membrane is formed by embedding hot pressing once.
  • Appearance should be clean, non-polluting, non-folding, conforming 0 32
  • Diameter ⁇ 10mm error must not exceed the payment 0
  • Filtration rate Filters particles above the nominal pore size
  • the number should be ⁇ 95%
  • the particle contamination should not exceed 50 / mL, 0
  • the number of particles dyed 15 ⁇ -25 ⁇ is not exceeded.
  • the number of particles larger than 25 ⁇ should not exceed
  • the amount of output should be ⁇ 25mL/mm 2
  • the absorbance of the UV absorption test solution should be no greater than 0
  • Bio bacteria should be less than 0.5E
  • This experiment examines the amount of particulate contamination when the glass bottle is opened.
  • Method 100 injections of ampoules and antibiotic glass bottles were respectively taken, and the drug was opened by the "disposable sterile microparticle-retaining syringe" of the present invention.
  • the size of the syringe was 10 ml, and the filter membrane was determined by the experiment PES.
  • the film has a flow rate of 0.14-0. 12mm.
  • the film has a flow rate of 31-44ml/cm 2 /min, a working temperature of 20 V, and a film thickness of 0.11-0. 12mm.
  • the drug solution was taken out and pushed out to the glass slide of the bio-inverted microscope through a syringe.
  • the number of particles in the drug solution was counted under a microscope, and the average results were recorded in the test group of Table 2.
  • the corresponding filter membrane was taken out, and the microscopic surface of the filter membrane was observed to block the 45 ⁇ m particles to 100%.
  • the membrane ring of the filter device (the filter holder composed of the upper cover and the lower cover) is attached to the membrane, and is opened and closed with the action of the syringe.
  • This experiment uses the push-pull airflow to test the stent and the filter membrane. The strength of the tensile strength of the tensile bending was observed.
  • a sterile microparticle-retaining syringe was used with a l ⁇ 50 ml empty cut. The empty cut ends with the fastest back to the end and back to the top for an action, ending 10 times. After each movement, observe whether the top-side bracket of the syringe is displaced in the inner cylinder, and then take out the filter device under the biological microscope to observe whether the filter-embedded stent is loose, whether the filter is deformed, and whether the stent is in the top of the syringe. Maintain the horizontal plane, whether the stent is inserted into the syringe as it is, whether the enveloping edge of the annular filter is detached, and whether the filter membrane is perforated between the membrane ring and the diaphragm.
  • the above 1 ⁇ 10 experimental results show that the filter membrane has not fallen off, the annular filter envelope is not detached, the stent device is not loose, and the filter membrane is not perforated, that is, everything is intact.
  • the filter device of the invention for emptying and disposable sterile particle-retaining syringe has no damage at one time, and its strength is qualified.
  • each deionized water is taken according to the nominal metering of the syringe, and then pushed into the 200ml measuring cup, each specification 10 times, a total of 110 simulations .
  • the measuring cup liquid was transferred 10 times to the biological inverted microscope piece, and the filtrate was observed under the microscope. The results showed no particle particles.
  • the end filter of the infusion set is microgravity (only relying on the gravity of the liquid), which is easy to block the pores of the membrane. Unless the gap between the membrane pore size and the particle size is large, the flow rate of the filtrate can be prevented from attenuating, but the pore diameter is increased. Large and obviously weakened the interception effect of the particles.
  • the principle of the disposable sterile particle trapping syringe of the present invention is that the filtration is carried out by pressure pushing, which is different from the filtering principle of the existing infusion set. Therefore, in the present invention, the pore size change of the membrane has no obvious attenuation hindrance, and as the fluence increases, the amount of particulate accumulation in the membrane surface also increases, and a part of the membrane is blocked, but the filtrate flow rate does not show a decay tendency.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Disclosed is a disposable sterile injector for retaining microparticles, which comprises an outer barrel (3), a liquid-ejecting rod (4) placed in the outer barrel (3) and a needle seat (5) on one side of the front end of the outer barrel (3) for mounting a needle. The injector also comprises a filtration unit (6). The filtration unit (6) is arranged with a filter membrane (12). The filter membrane (12) is attached to a liquid outlet and closed at the front end and open at the back end. A thickening interlayer is set on the top end of a traditional injector; a circular unilateral hanging filtration unit is embedded in the interlayer. The filtration unit can be open and closed automatically as the liquid flows, and retains the microparticles in the injection solution once; no microparticles of ≥0.45um appear in the solution ejected, which ensures the safety of the injection.

Description

一次性使用无菌微粒截留注射器 技术领域  Single use sterile particle trapping syringe
本发明属于医疗器械领域, 涉及一种注射器, 尤其涉及一种一次性使用无 菌微粒截留注射器。  The invention belongs to the field of medical devices, and relates to a syringe, in particular to a disposable sterile particle trapping syringe.
背景技术 Background technique
输液治疗是一种重要的治疗手段, 尤其是静脉输液和静脉注射由于药液直 接进入血液循环系统, 药效发挥快而被广泛采用。 然而, 近年来, 注射液特别 是输液中异物与微粒污染所造成的危害, 已引起人们的普遍关注, 解决微粒污 染已刻不容缓。  Infusion therapy is an important treatment, especially intravenous infusion and intravenous injection. Because the drug directly enters the blood circulation system, its efficacy is rapidly used. However, in recent years, the harm caused by the injection of foreign bodies and particulates in infusions has caused widespread concern, and it has become urgent to solve the problem of particulate contamination.
静脉点滴及静脉注射, 微粒是指存在于液体中的非故意加入可游动的、 不溶 性的外源物质及可溶而未溶的药物, 不溶性微粒包括橡胶微粒、 涤纶薄片、 薄 屑、 色点、 不溶性无机盐、 活性炭微粒、 纤维及联合用药配伍不当所产生的化 学微粒等, 如果这些微粒混入输液中, 临床应用时就可能引起输液反应, 可能 导致急性反应或长期潜在危险。 如, 微粒的大量注入人体可能产生严重的机体 损害, 微粒在体内潜伏期可长达数十年无法代谢, 较大微粒随血液循环在小血 管滞留形成堵塞, 造成不同程度的组织坏死和损伤, 如静脉炎, 肺部肉芽肿, 血栓形成及血管栓塞, 诱发肿瘤形成等, 甚至危及病人生命。 鉴于药液中微粒 污染可能导致的严重后果, 我国 《药典》 规定, 每毫升输液中粒径〉 ΙΟ μ πΐ (微 米) 的不溶性微粒不得超过 10个。  Intravenous drip and intravenous injection, microparticles are unintentionally added to the swimming, insoluble exogenous substances and soluble and undissolved drugs, insoluble particles including rubber particles, polyester flakes, thin chips, color points Inorganic salts, insoluble inorganic salts, activated carbon microparticles, fibers, and chemical particles produced by improper combination of drugs, if these particles are mixed into the infusion, clinical application may cause an infusion reaction, which may lead to acute reactions or long-term potential risks. For example, a large amount of particles injected into the human body may cause serious damage to the body. The latent period of the particles in the body can be metabolized for decades, and the larger particles are blocked by the blood circulation in the small blood vessels, causing different degrees of tissue necrosis and damage, such as Phlebitis, pulmonary granuloma, thrombosis and vascular embolism, induce tumor formation, etc., and even endanger the patient's life. In view of the serious consequences of particulate contamination in liquid medicine, the Pharmacopoeia of China stipulates that no more than 10 insoluble particles with a particle size > ΙΟ μ π ΐ (millimeters) per ml of infusion.
药液中微粒来源可能有以下几种:  The sources of particles in the liquid may be the following:
1.物品和输液器生产工艺中带来。  1. Brought in the production process of articles and infusion sets.
2.药物配制过程中的不正确操作产生, 如多种药物配伍时, 可能在药液中存 在 1〜50 μ m以上的药物微粒。  2. Incorrect operation during drug preparation. For example, when multiple drugs are compatible, there may be more than 1~50 μm of drug particles in the drug solution.
3.玻璃安瓿启开时吸入的玻璃碎屑。  3. Glass debris inhaled when the glass ampoule is opened.
4.针头穿刺瓶塞溶药切割下的塞屑。  4. Needle puncture bottle stopper Dissolve the cuttings under the drug.
5.输液器的塑料针在插入液体瓶胶塞时, 亦可使液体中微粒增加 1. 6〜27. 6 倍。  5. The plastic needle of the infusion device can also increase the amount of particles in the liquid by 1. 6~27. 6 times when inserting the liquid bottle rubber plug.
消除输液中微粒污染的主要方式是加装微型滤器使药液进入人体之前先经 过过滤。 已有研究人员针对输液器加装一种夹有滤膜的过滤装置, 该过滤装置 安装在输液器终端 (滴斗的下端), 过滤原理是依靠吊瓶内液体下沉所产生的负 压实现过滤。 在这一环节添加过滤装置确实解决了部分微粒污染问题, 但该带 过滤装置输液器, 价格显著增加, 增加了患者负担; 而另一方面, 该带过滤装 置的输液器, 过滤 500〜1500ml 液体后随着微粒的积聚, 还存在过滤装置膜孔 堵塞、 影响初始流量、 滤速衰减等现象而导致输液器无法正常输液。 The main way to eliminate particulate contamination in the infusion is to add a microfilter to filter the solution before it enters the body. Researchers have installed a filter device with a filter on the infusion set. The filter device is installed at the end of the infusion set (the lower end of the drip bucket). The filtration principle is realized by the negative pressure generated by the liquid sinking in the bottle. filter. Adding a filter device at this stage does solve some of the particulate contamination problems, but the price of the infusion set with the filter device is significantly increased, which increases the burden on the patient; on the other hand, the filter pack After the infusion set is filtered, 500~1500ml of liquid is filtered, and as the particles accumulate, there is also a phenomenon that the membrane pores of the filter device are clogged, affecting the initial flow rate, and the filtration rate is attenuated, so that the infusion set cannot be normally infused.
静脉注射途径给药是常见的治疗方法。 目前, 一次性使用的无菌注射器结构 十分经典, 其仅能完成单纯的抽吸注射功能, 而改进研究更多集中在如何保证 一次性使用以及注射器本身的处置安全性上, 这些研究成果均不涉及如何消除 微粒污染。 随着医疗质量管理体系的完善和病人对于治疗手段纯净度要求的提 高, 加强对静脉注射液中不溶性微粒控制及减少不溶性微粒对静脉注射病人的 危害, 愈来愈被医院和病人所重视。 然而到目前为止尚没有任何形式的过滤装 置能在注射器中安全使用, 用于输液器中的过滤装置由于其截留原理的不同也 无法转用于注射器中, 除外接式过滤注射器外, 安装微型过滤装置于一体的一 次性使用无菌微粒截留注射器的产品还没有出现。  Administration by intravenous route is a common treatment. At present, the disposable sterile syringe structure is very classic, it can only perform the simple aspiration injection function, and the improvement research is more focused on how to ensure the disposable use and the safety of the treatment of the syringe itself. It involves how to eliminate particulate pollution. With the improvement of the medical quality management system and the improvement of the patient's requirements for the purity of the treatment means, strengthening the control of insoluble particles in the intravenous solution and reducing the harm of insoluble particles to intravenous patients are increasingly being valued by hospitals and patients. However, so far no filter device of any kind can be safely used in the syringe. The filter device used in the infusion set cannot be transferred to the syringe due to the different retention principle. Except for the connection filter syringe, the micro filter is installed. The product of the one-piece disposable sterile particulate retention syringe has not yet appeared.
发明内容 Summary of the invention
本发明目的在于提供一种安装有微型滤器的可以对注射液进行微粒截留的 一次性使用无菌微粒截留注射器。  SUMMARY OF THE INVENTION It is an object of the present invention to provide a disposable sterile particulate retentive syringe which is provided with a microfilter and which is capable of particulate trapping of the injectable solution.
本发明一次性使用无菌微粒截留注射器, 包括外筒、 置于外筒内的推液杆 和外筒前端一侧用于装针的针座, 外筒和针座以出液口连通, 还包括一过滤装 置, 该过滤装置设一过滤膜, 该过滤膜附于出液口, 且向前端封闭, 向后端开 启。  The disposable sterile particle trapping syringe of the invention comprises an outer cylinder, a push rod placed in the outer cylinder and a needle seat for loading the needle on the front end side of the outer cylinder, and the outer cylinder and the needle seat are connected by the liquid outlet, A filtering device is disposed, the filtering device is provided with a filtering membrane attached to the liquid outlet, and is closed to the front end and opened to the rear end.
所述过滤装置包埋在外筒最顶端前壁。  The filter device is embedded in the topmost front wall of the outer cylinder.
所述过滤装置包括一插件, 过滤膜固定在该插件中, 所述外筒最顶端前壁 靠针座的一侧沿外筒弧线方向开设与该插件匹配的装配长孔, 该插件装配于该 长孔内。  The filter device includes an insert, and a filter membrane is fixed in the insert. The top end front wall of the outer cylinder is disposed on the side of the needle seat along an arc of the outer cylinder to form an assembly long hole matching the insert. Inside the long hole.
所述插件包括顺序连为一体的销头、 连接片和中空的膜圈, 所述过滤膜固 定在膜圈上, 连接片和膜圈在外筒之内, 销头在外筒之外。  The insert comprises a pin head, a connecting piece and a hollow membrane ring which are integrally connected in series, the filter membrane being fixed on the membrane ring, the connecting piece and the membrane ring being inside the outer cylinder, and the pin head being outside the outer cylinder.
所述过滤膜被固定在一组对扣的上盖和下盖之间形成膜片, 过滤膜以该膜 片的形式被装配。  The filter membrane is fixed between a top cover and a lower cover of a pair of buckles to form a membrane, and the filter membrane is assembled in the form of the membrane.
所述上盖和下盖为圈体, 圈体的中空部分设有用以托衬过滤膜的网格, 上 盖和下盖的圈体实体部分分别设对位固定的凹痕和凸起。  The upper cover and the lower cover are ring bodies, and the hollow portion of the ring body is provided with a mesh for lining the filter film, and the solid portions of the upper cover and the lower cover are respectively provided with indented fixed protrusions and protrusions.
所述外筒最顶端前壁内侧对应膜片位置开设定位凹槽, 且该定位凹槽尺寸大 于膜片边沿尺寸 0. 05腿。  The positioning of the positioning groove is larger than the size of the diaphragm edge 0. 05 leg.
所述外筒最顶端前壁加厚至 4mm。  The outermost front wall of the outer cylinder is thickened to 4 mm.
所述外筒前端在装有膜片的一侧为增厚至 2mm的半圆锥形受力侧壁。  The front end of the outer cylinder is a semi-conical force-receiving side wall thickened to 2 mm on the side where the diaphragm is mounted.
所述膜片的上盖厚 0. 15匪, 下盖厚 0. 05mm, 过滤膜厚 0. 11-0. 12匪; 所述插 件的销头厚 12mm, 连接片厚度 0. 32mm, 膜圈厚 0. 35mm; 所述销头的弧线长度大 于外筒装配长孔的弧线长度。 0 匪; The insertion of the thickness of the upper cover is 0. 05 匪, the thickness of the lower cover is 0. 05 mm, the thickness of the filter film is 0. 11-0. The thickness of the pin head is 12 mm, the thickness of the connecting piece is 0.332 mm, and the thickness of the film ring is 0. 35 mm ; the length of the arc of the pin head is larger than the length of the arc of the long hole of the outer tube assembly.
采用以上设计, 本发明一次性使用无菌截留注射器可将注射液中的微粒一次 截留, 绝对控制推出液中不再产生 45 μ πι以上微粒, 该带截留的注射器抽取 药液可直接静推肌注, 保证了注射安全。 另一方面, 使用该带截留的注射器配 合输液时, 抽取药液注入吊瓶中已去除了其它环节产生的微粒, 因此, 输液器 终端所带过滤装置只需阻滤输液器自身通道所产生的微粒, 这样会减轻输液器 终端过滤装置堵塞、 滤速衰减、 影响初始流量的现象发生。  With the above design, the single-use sterile trapping syringe of the present invention can temporarily remove the particles in the injection liquid, and absolutely control the particles in the ejection liquid to no longer generate 45 μππ or more, and the syringe with the trapping liquid can directly push the muscles. Note that injection safety is guaranteed. On the other hand, when the syringe with the trap is used in combination with the infusion, the injection of the liquid into the bottle has removed the particles generated by other links. Therefore, the filter device at the end of the infusion device only needs to block the infusion of the infusion device. Particles, which will reduce the blockage of the filter device at the end of the infusion set, the attenuation of the filtration rate, and the occurrence of initial flow.
本发明优点在于:  The advantages of the invention are:
1.一次性使用无菌微粒截留注射器为一次性使用。  1. One-time use of sterile microparticle-retaining syringes for single use.
2.一次性使用无菌微粒截留注射器外观十分简单, 但使用时微粒截留率达百 分之百。  2. The appearance of a single-use sterile particle-retaining syringe is very simple, but the particle retention rate is 100% when used.
3.—次性使用无菌微粒截留注射器不改变护理注射领域医务人员传统注射 操作习惯, 保留了传统外观, 使注射操作从视觉、 直觉、 感观直角平面等与传 统操作完全一致。  3. The use of sterile microparticle-retaining syringes does not change the traditional injection procedure of medical personnel in the field of nursing injection, retaining the traditional appearance, and making the injection operation completely consistent with the traditional operation from the visual, intuitive, and sensory right-angle planes.
4.一次性使用无菌微粒截留注射器呈现夹层包埋的过滤装置, 其膜片静态自 行关闭、 抽吸自行开启、 推液自行闭合, 同时强制液体必经滤膜通道, 有效阻 截微粒。  4. Disposable sterile microparticle-retaining syringe presents a sandwich-embedded filter device. The diaphragm is statically closed, the suction is self-opening, and the pusher is self-closing. At the same time, the liquid must be forced through the membrane channel to effectively block the particles.
5.该结构的设计, 仅在一支传统而普通的注射器顶端, 设增厚夹层包埋一圆 型单侧挂式过滤装置, 该装置可随液体微流自行开启闭合并实现溶药的抽吸, 随心所欲。  5. The design of the structure is only on the top of a conventional and ordinary syringe, with a thickened interlayer embedded with a circular single-sided hanging filter device, which can open and close with the liquid microfluid and realize the pumping of the solvent. Suck, do whatever you want.
6.确保护理操作注射领域无论采用什么样方法溶药、 微粒来自于什么样渠 道, 溶药完毕即可随欲抽吸随欲推出, 实现微粒的完全截留而不被引入重力输 液及袋装输液, 避免了如抢救、 静脉滴注、 静脉注射时微粒进入人体血液循环 系统带来的危害, 微粒截留率安全系数达 100 %。  6. Ensuring the operation of the injection field No matter what method is used to dissolve the drug, and the channel from which the particles come from, the drug can be pushed out as desired, and the complete retention of the particles can be realized without being introduced into gravity infusion and bagged infusion. It avoids the harm caused by particles entering the human blood circulation system during rescue, intravenous drip, and intravenous injection, and the particle retention rate safety factor is 100%.
附图说明 DRAWINGS
图 1为本发明一次性使用无菌微粒截留注射器结构示意图;  Figure 1 is a schematic view showing the structure of a single-use sterile particle trapping syringe of the present invention;
图 2为本发明一次性使用无菌微粒截留注射器中膜片构成图;  Figure 2 is a schematic view showing the structure of a diaphragm in a disposable sterile microparticle-retaining syringe of the present invention;
图 3为本发明一次性使用无菌微粒截留注射器中过滤装置的结构图; 图 4为本发明一次性使用无菌微粒截留注射器中外筒 3的前端结构剖面图; 图 5为图 4的左视图 (外筒部分);  Figure 3 is a structural view of a filtering device in a single-use sterile microparticle-retaining syringe of the present invention; Figure 4 is a cross-sectional view showing the front end structure of the outer cylinder 3 in a disposable sterile particle-retaining syringe of the present invention; Figure 5 is a left side view of Figure 4 (outer tube part);
图 6为本发明一次性使用无菌微粒截留注射器中过滤装置 6的装配图; 图 7为图 6装配完成后注射器外筒前端的结构图; 图 8为本发明一次性使用无菌微粒截留注射器使用时过滤装置 6中膜片 1 的变化状态图, A幅为准备抽吸状态, B幅为吸液状态, C幅为推液状态, D幅 为完成注射状态。 Figure 6 is an assembled view of the filter device 6 in the disposable sterile particle trapping syringe of the present invention; Figure 7 is a structural view of the front end of the syringe outer tube after the assembly of Figure 6 is completed; Fig. 8 is a view showing a state of change of the diaphragm 1 in the filtering device 6 when the disposable sterile particle trapping syringe of the present invention is used, wherein the A frame is in a state of being sucked, the B frame is in a liquid absorption state, and the C frame is a liquid pushing state, D The frame is in the state of completion of injection.
具体实施方式 detailed description
本发明提供一种一次性使用无菌微粒截留注射器, 针对现有结构注射器做 出改造, 在其顶端加设一过滤装置, 以达到注射时能对药液中微粒进行截留保 证注射安全的目的。  The invention provides a disposable sterile particle trapping syringe, which is modified for the existing structure syringe, and a filtering device is added at the top end thereof to achieve the purpose of intercepting and ensuring safe injection of the particles in the liquid medicine during the injection.
如图 1 所示, 本发明提供的一次性使用无菌微粒截留注射器, 包括现有普 通注射器的外筒 3、 置于外筒内的推液杆 4和外筒前端一侧用于装针的针座 5, 本发明的特点是, 还包括一过滤装置 6, 其包埋在外筒 3最前端内壁, 并正对针 座 5出液口位置。  As shown in Fig. 1, the present invention provides a single-use sterile particle trapping syringe, which comprises an outer cylinder 3 of a conventional ordinary syringe, a push rod 4 placed in the outer cylinder, and a front end side of the outer cylinder for needle loading. The needle holder 5, which is characterized by the present invention, further comprises a filtering device 6 which is embedded in the innermost wall of the outermost end of the outer cylinder 3 and which faces the position of the liquid outlet of the needle holder 5.
该过滤装置 6由一膜片 1和一插件 2组成, 参见图 3所示。 其中:  The filter unit 6 consists of a diaphragm 1 and an insert 2, as shown in Fig. 3. among them:
如图 2所示, 膜片 1顺序由上盖 11、过滤膜 12和下盖 13热压而成一椭圆形 片状体, 上盖 1 1和下盖 13为滤膜支架, 呈圈体状, 圈体的中空部分设有网格 14用以托衬过滤膜 12, 上盖 11和下盖 13的圈体实体部分分别设对位固定的凹 痕和凸起, 过滤膜 12为片体, 置于上盖 1 1和下盖 13之间并对位于网格 14位 置, 上盖 11与下盖 13以凹痕与凸起对位后经热压, 将过滤膜 12压制在上下盖 之间, 形成膜片 1 ( "夹层"概念)。  As shown in FIG. 2, the diaphragm 1 is sequentially pressed by the upper cover 11, the filter membrane 12 and the lower cover 13 to form an elliptical sheet-like body, and the upper cover 11 and the lower cover 13 are filter holders, and are formed in a ring shape. The hollow portion of the ring body is provided with a mesh 14 for lining the filter film 12, and the solid portions of the upper cover 11 and the lower cover 13 are respectively provided with indented fixed protrusions and protrusions, and the filter film 12 is a sheet body. Between the upper cover 11 and the lower cover 13 and at the position of the grid 14, the upper cover 11 and the lower cover 13 are pressed by the indentations and the protrusions, and then the hot film is pressed, and the filter film 12 is pressed between the upper and lower covers. Forming the diaphragm 1 ("sandwich" concept).
优选的, 膜片 1的上盖 1 1由聚丙烯材质制成, 厚 0. 15腿; 下盖 13由 PP材 质制成, 厚 0. 05mm ; 过滤膜 12 可采用聚醚砜膜(孔径 0. 45 μ πι), 厚度 00. 1 1-0. 12mm。 5毫米; The upper cover 13 is made of a polypropylene material, and has a thickness of 0.15 legs; the lower cover 13 is made of PP material, and has a thickness of 0.05 mm ; the filter film 12 can be made of a polyethersulfone film (aperture 0). 45 μ πι), thickness 00. 1 1-0. 12mm.
参见图 3, 插件 2整体为片状, 包括顺序连为一体的销头 21、 连接片 22和 膜圈 23, 形似铆钉, 销头 21外沿呈弧线, 内沿接连接片 22, 连接片 22中镂空 开出一空圈形成膜圈 23用于装设膜片 1。插件 2整体由 PP材料一体制成, 销头 21厚 12mm, 连接片 22厚 0. 2mm, 膜圈厚 0. 35mm, 插件 2整体长 15mm。  Referring to Fig. 3, the insert 2 is integrally formed in a sheet shape, and includes a pin head 21, a connecting piece 22 and a membrane ring 23 which are integrally connected in series, and is shaped like a rivet. The outer edge of the pin head 21 is curved, the inner connecting piece 22 is connected, and the connecting piece is connected. In the middle 22, an open loop is formed to form a diaphragm 23 for mounting the diaphragm 1. The insert 2 is integrally made of PP material, the pin head 21 is 12 mm thick, the connecting piece 22 is thick 0. 2 mm, the film ring thickness is 0. 35 mm, and the insert 2 is 15 mm overall.
将膜片 1放置于插件 2的膜圈 23位置, 经热压固定形成过滤装置 6 (参见图 3)。 很显然, 过滤装置中过滤膜 12和膜圈 23的尺寸应与注射器的规格 (规格 lml〜100ml共 11个规格) 相匹配。  The diaphragm 1 is placed at the position of the diaphragm 23 of the insert 2, and fixed by a heat press to form a filter unit 6 (see Fig. 3). It is apparent that the size of the filter membrane 12 and the membrane ring 23 in the filter unit should match the size of the syringe (11 specifications in specifications lml to 100 ml).
为装配该过滤装置 6, 本发明的注射器外筒 3前端需做调整。 调整包括: 一) 注射器顶端出液口以中线计算, 向注射器中轴线移位 3 mm;  In order to assemble the filter device 6, the front end of the syringe outer cylinder 3 of the present invention needs to be adjusted. Adjustments include: a) The top outlet of the syringe is calculated from the center line and displaced 3 mm to the center axis of the syringe;
二) 参见图 4-图 5所示, 注射器外筒 3的顶端的前壁 31需增厚 (见图 4和 图 5),通常可加厚至 4 mm,目的是将注射器外筒 3的顶端壁面由原有较薄( 1. 5腿) 加厚 ( "增厚"概念), 以利于下述三) 的开口设计; 三) 在该前壁 31靠针座 5的一侧 ( "单侧"概念) 沿外筒弧线方向开设装 配长孔 32 (例如, 孔厚 0. 35腿, 弧线长 20腿)用于将过滤装置 6插入, 装配长 孔 32的弧线长度(20mm)小于销头 21的弧线长度(销头厚 36mm,长 2 101111 ), 以将过滤装置 6定位; 且在外筒 3前壁 31内侧对应该装配长孔 32的位置开设 定位凹槽 33 (槽厚 0. 35mm,宽 12. mm,长 15腿)用于容纳过滤装置 6, 该定位凹槽 33的尺寸大于过滤装置 6的膜片 1 (进槽边沿) 0. 05mm (参见图 4), 为注射器使 用时膜片 1的开启闭合留出空间, 不卡槽且关闭自如 ( "包埋"概念); b) As shown in Figures 4 to 5, the front wall 31 of the top end of the syringe barrel 3 is thickened (see Figures 4 and 5) and can be generally thickened to 4 mm for the purpose of placing the top of the syringe barrel 3 The wall is thickened by the original thinner (1.5 legs) ("thickening" concept) to facilitate the opening design of the following three); 3) On the side of the front wall 31 against the needle holder 5 ("one-sided" concept), an elongated hole 32 is opened along the arc of the outer cylinder (for example, a hole thickness of 0.35 legs and an arc length of 20 legs) is used for The filter device 6 is inserted, and the arc length (20 mm) of the assembly long hole 32 is smaller than the arc length of the pin head 21 (the pin head thickness is 36 mm, the length is 2 101111) to position the filter device 6; and the front wall 31 of the outer tube 3 The inner side is disposed with the positioning hole 33 at a position where the long hole 32 is to be assembled (the groove thickness is 0.35 mm, the width is 12. mm, and the length is 15 legs) for accommodating the filtering device 6, and the positioning groove 33 is larger in size than the film of the filtering device 6. Sheet 1 (inlet edge) 0. 05mm (see Figure 4), leaving space for opening and closing of diaphragm 1 when using the syringe, without snapping and closing freely ("embedding"concept);
四) 为增加注射器筒体强度, 外筒 3在开有装配长孔 32的一侧的侧壁需加 厚,加厚的方式为该外筒 3侧壁形成一半圆锥形受力侧壁 34(参见图 5,厚 2mm X 宽 15mm X长 20mm), 加厚增强的受力侧壁 34可以保证过滤装置 6插入外筒 3前 壁 31的装配长孔 32时外筒 3具有足够的强度和承载力 ( "加强 "概念)。  4) In order to increase the strength of the syringe barrel, the side wall of the outer tube 3 on the side on which the long hole 32 is formed needs to be thickened in such a manner that the side wall of the outer tube 3 forms a semi-conical force-receiving side wall 34 ( Referring to Fig. 5, the thickness is 2 mm X width 15 mm X length 20 mm), the thickened reinforcing force side wall 34 can ensure that the outer tube 3 has sufficient strength and load when the filter device 6 is inserted into the assembled long hole 32 of the front wall 31 of the outer cylinder 3. Force ("strengthening" concept).
以上经一)至四) 调整后的增厚加强单侧开槽的注射器外筒 3为一体注塑成 型。  The above-mentioned one to four) adjusted thickening reinforced single-side slotted syringe outer cylinder 3 is integrally molded.
装配中, 将过滤装置的膜片 1朝向注射器外筒 3, 从装配长孔 32插入前壁 31进入定位凹槽 33中 (参见图 6), 插件 2的销头 21卡在装配长孔 32之外固 定 ( "挂式"概念), 参见图 7, 显示了装配完成后注射器外筒前端的结构, 以 此装配得到具有增厚加强夹层包埋一圆型单侧挂式过滤装置的一次性使用无菌 微粒截留注射器 (参见图 1, 针座 5上已装上针头)。  In the assembly, the diaphragm 1 of the filtering device is directed toward the syringe outer cylinder 3, inserted into the front wall 31 from the fitting long hole 32 into the positioning recess 33 (see Fig. 6), and the pin head 21 of the insert 2 is caught in the fitting long hole 32. External fixation ("hanging" concept), see Figure 7, shows the structure of the front end of the outer cylinder of the syringe after assembly, and the assembly is used to obtain a one-time use of a thickened and reinforced laminated embedded circular one-side filter device. Sterile particle trapping syringe (see Figure 1, the needle is attached to the needle hub 5).
使用时, 本发明一次性使用无菌微粒截留注射器过滤装置中膜片 1的变化参 见图 8所示, 其中:  In use, the variation of the membrane 1 in the disposable sterile particulate retentive syringe filtration device of the present invention is shown in Figure 8, wherein:
A幅显示一次性使用无菌微粒截留注射器已空拉气流, 注射器推液杆 4处于 针筒最前端, 进入准备抽吸状态, 此时膜片 1位于凹槽中, 处于关闭状态; The A-frame shows that the disposable sterile particle-retaining syringe has been air-drawn, and the syringe push-pull rod 4 is at the foremost end of the syringe, and is ready to be sucked. At this time, the diaphragm 1 is located in the groove and is in a closed state;
B幅显示一次性使用无菌微粒截留注射器实施抽吸动作, 注射器推液杆 4后 拉, 药液从吸液孔进入, 向后推开膜片 1进入注射器针筒内, 此时膜片 1处于 开启状态; B-frame shows the single-use sterile microparticle-retaining syringe to perform the pumping action. The syringe push-pull rod 4 is pulled back, the liquid medicine enters from the liquid-suction hole, and the diaphragm 1 is pushed back into the syringe barrel. At this time, the diaphragm 1 Is turned on;
C幅显示一次性使用无菌微粒截留注射器实施推液动作, 注射器推液杆 4前 推, 液压推动膜片 1从开启状态向前呈关闭状态, 药液通过膜片 1 的孔隙被推 出;  The C-frame shows a one-time use of a sterile microparticle-retaining syringe to perform a pushing action, and the syringe push-pull rod 4 is pushed forward, and the hydraulically-driven diaphragm 1 is closed from the open state to the forward state, and the liquid medicine is pushed out through the aperture of the diaphragm 1;
D幅显示一次性使用无菌微粒截留注射器推液完成, 此时注射器推液杆 4被 推至针筒最前端, 膜片 1位于凹槽中, 处于关闭状态, 药液已通过膜片 1 的孔 隙被推出, 而药液中存在的微粒被膜片 1拦截, 存留在针筒内。  The D-frame shows the completion of the single-use sterile microparticle-retaining syringe pusher, at which point the syringe push-pull rod 4 is pushed to the foremost end of the syringe, the diaphragm 1 is located in the groove, and is closed, and the liquid medicine has passed through the diaphragm 1 The pores are pushed out, and the particles present in the liquid are intercepted by the membrane 1 and remain in the syringe.
通过以上一次注射操作流程可以看到, 装有过滤装置的注射器, 在药液中存 在不可预知或难以避免的微粒时, 膜片可以有效将微粒截留, 保证了输入人体 的药液中不存在微粒, 消除了严重困扰输液安全性的微粒污染。 Through the above injection operation procedure, it can be seen that when the syringe equipped with the filtering device has unpredictable or unavoidable particles in the liquid medicine, the diaphragm can effectively intercept the particles and ensure the input into the human body. There are no particles in the liquid, which eliminates particulate contamination that seriously plagues the safety of the infusion.
从本发明产品本身安全性考虑, 滤膜支架(上盖和下盖)采用 PP材质制造, 不含双酚 A物质, 其安全性完全符合欧盟标准, 并且具备不易碎裂和稳定性好 等优点, 即使是在高温加热的情况下, 也不会释放出有害的物质; 过滤膜为包 埋热压一次成型。  From the safety consideration of the product itself, the filter holder (upper cover and lower cover) is made of PP material, does not contain bisphenol A substance, and its safety is fully in line with EU standards, and has the advantages of not easy to be broken and stable. Even in the case of high temperature heating, no harmful substances are released; the filter membrane is formed by embedding hot pressing once.
以下通过相关实验进一歩说明本发明的一次性使用无菌微粒截留注射器的 功用及效果。  The function and effect of the single-use sterile microparticle-retaining syringe of the present invention will be further explained below by related experiments.
实验一: 一次性使用无菌微粒截留注射器中过滤膜材料的检验  Experiment 1: Inspection of filter membrane material in disposable sterile particulate trapping syringe
本实验针对一次性使用无菌微粒截留注射器中所用过滤膜材料进行实验, 确证所用膜材料的截留效果、 疏水透气性能以及安全性能。 其中针对微孔聚醚 砜滤膜的检验结果参见表 1, 表明所选用的过滤膜材料可用。选用其它滤膜前也 需进行类似检测, 文中不再一一罗列检测结果。  This experiment was conducted on the filter membrane material used in the disposable sterile microparticle-retaining syringe to confirm the retention effect, hydrophobic gas permeability and safety performance of the membrane material used. The test results for the microporous polyethersulfone filter are shown in Table 1, indicating that the selected filter membrane material is available. Similar tests are required before other filters are used. The results are not listed here.
表 1 一次性使用医用微孔聚醚砜滤膜逐批试验报告
Figure imgf000008_0001
Table 1 Batch-by-batch test report of disposable medical microporous polyethersulfone filter
Figure imgf000008_0001
检验依据 ΥΖΒ/国 1979-2011 报告日期 2012、 4、 16  Inspection basis ΥΖΒ/Country 1979-2011 Report date 2012, 4, 16
检验项目 标准要求 实测结果 不合格数 抽样方案 判  Inspection items Standard requirements Measured results Unqualified number Sampling plan Judgment
 Set
外观 应清洁、 无污染、 无折叠、 符合 0 32  Appearance should be clean, non-polluting, non-folding, conforming 0 32
无缺角、 无损伤  No corners, no damage
直径 < 10mm误差不得超过 付口 0  Diameter < 10mm error must not exceed the payment 0
尺寸 ±0.2mm。 13  Size ± 0.2mm. 13
物理 >10mm 的滤膜误差不得超  Physical >10mm filter error can not exceed
性能 过 ±0.3mm。  Performance is over ±0.3mm.
滤除率 滤除标称孔径以上的微粒 付口 0 格  Filtration rate Filters particles above the nominal pore size
数应≥95%  The number should be ≥95%
滤速 -0.093Mpa 下 滤 速 应 付口 0  Filtration speed -0.093Mpa under the filter speed should be paid 0
>7mL/cm2.min >7mL/cm 2 .min
洗脱液中 5μπι 以上的微粒  Particles above 5μπι in the eluent
微粒污 数不应超过 50 个 / mL, 0  The particle contamination should not exceed 50 / mL, 0
染 15μπι-25μπι 的微粒数不超 付口  The number of particles dyed 15μπι-25μπι is not exceeded.
过 10个 / mL,  Over 10 / mL,
大于 25μπι的微粒数不应超  The number of particles larger than 25μπι should not exceed
过 3.0个 / mL 20  Over 3.0 / mL 20
疏水性 阻水压大于 15KPa 付口 0  Hydrophobic water blocking pressure greater than 15KPa
气体流 单位面积 lOmin 气体流出 付口 0  Gas flow unit area lOmin gas outflow payout 0
出量 量应≥25mL/mm2 The amount of output should be ≥25mL/mm 2
检验液和空白液消耗高锰  Test solution and blank solution consume high manganese
化学 还原物 酸钾溶液的体积之差应不 0.6 0 性能 质 超过 2.0mL 全部 The difference between the volume of the chemical reduction potassium acid solution should not be 0.6 0 Performance quality exceeds 2.0mL
酸碱度 检验液与空白液 pH值之差 0.30 0  pH difference between test solution and blank solution pH value 0.30 0
应不超过 1.5。  Should not exceed 1.5.
 Grid
紫外吸 检验液的吸光度应不大于 符合 0  The absorbance of the UV absorption test solution should be no greater than 0
光度 0.1。  Luminosity 0.1.
生物 细菌 内 应小于 0.5E|i/mL 符合 0  Biological bacteria should be less than 0.5E|i/mL within 0
性能 毒素 结论:
Figure imgf000009_0001
Performance Toxin Conclusion:
Figure imgf000009_0001
优点: 具有优良的耐热性和耐化学性,无粉末或纤维脱落现象, 韧性良好 实验二: 注射器微粒截留率实验  Advantages: Excellent heat resistance and chemical resistance, no powder or fiber shedding, good toughness. Experiment 2: Syringe particle rejection test
本实验考查玻璃瓶开启时的微粒污染量。 方法: 分别取用安瓿与抗生素玻 璃瓶包装的注射液各 100支, 用本发明 "一次性使用无菌微粒截留注射器"按 常规开启吸药, 注射器规格 10ml, 其中过滤膜采用实验一确定的 PES , 孔径 0. 45 μ πι, 泡压 0. 31Mpa, 滤膜允许通过流量 31-44ml/cm2/min, 工作温度 20 V , 膜厚度 0. 1 1-0. 12mm。 抽取药液后经注射器推出至生物倒直显微镜的玻璃载片, 显微镜下观察计数得到药液中的微粒数量, 平均结果记录于表 2试验组中。 另 外取出对应过滤膜, 镜下观察过滤膜纳污面阻截 45 μ m微粒达百分之百。 This experiment examines the amount of particulate contamination when the glass bottle is opened. Method: 100 injections of ampoules and antibiotic glass bottles were respectively taken, and the drug was opened by the "disposable sterile microparticle-retaining syringe" of the present invention. The size of the syringe was 10 ml, and the filter membrane was determined by the experiment PES. The film has a flow rate of 0.14-0. 12mm. The film has a flow rate of 31-44ml/cm 2 /min, a working temperature of 20 V, and a film thickness of 0.11-0. 12mm. The drug solution was taken out and pushed out to the glass slide of the bio-inverted microscope through a syringe. The number of particles in the drug solution was counted under a microscope, and the average results were recorded in the test group of Table 2. In addition, the corresponding filter membrane was taken out, and the microscopic surface of the filter membrane was observed to block the 45 μm particles to 100%.
对照实验: 对以上所述同样注射液 100支, 用普通同规格注射器按常规方法 开启吸药, 抽取的药液移至生物倒直显微镜的玻璃载片, 显微镜下观察计数药 液中的微粒数量, 平均结果记录于表 2对照组中。 表 2不同注射器推出药液中微粒含量 (个 /ml )  Control experiment: For the same injection solution as described above, open the drug in the usual way with a normal syringe of the same specification. The extracted liquid is transferred to the glass slide of the bio-inverted microscope, and the number of particles in the counting solution is observed under the microscope. The average results are reported in the control group of Table 2. Table 2 The content of particles in the liquid of different syringes ( /ml)
Figure imgf000009_0002
Figure imgf000009_0002
实验结果表明, 使用普通注射器, 注射液中存在大量的微粒, 不符合行业中 的相关标准指标要求 (参见表 3), 分析其中微粒来源, 可归纳为表 4所列。 而 本发明一次性使用无菌微粒截留注射器后,推出注射液中 45 μ m的微粒全部 被截留, 保证了注射液的安全。 表 3: 各方法检测指标 The experimental results show that the use of ordinary syringes, there are a large number of particles in the injection, does not meet the relevant standard indicators in the industry (see Table 3), analyze the source of the particles, can be summarized as Table 4. And After the disposable sterile particle trapping syringe of the invention is used, all the particles of 45 μm in the injecting solution are trapped, thereby ensuring the safety of the injection solution. Table 3: Test indicators for each method
Figure imgf000010_0001
表 4: 注射液中微粒来源
Figure imgf000010_0001
Table 4: Sources of particulates in injections
序号 徵粒名称 来源  No. Name of the granule Source
1 橡胶微粒 注射针头刃角穿刺切割胶盖  1 rubber particles injection needle edge puncture cutting rubber cover
2 塑料微粒 药液包装  2 plastic particles
3 玻璃碎屑微粒 安瓿开启  3 glass crumb particles
4 结晶体微粒 药物置放和配伍  4 Crystal particles Drug placement and compatibility
5 纤维微粒 室内环境与输液器自污  5 fiber particles indoor environment and infusion set self-contamination
6 毛絮、 尘埃埃 室内环境与输液器自污  6 fluff, dust, indoor environment and infusion set self-contamination
7 碳黑微粒 药物生产过程  7 carbon black particles drug production process
8 脂肪酸微粒 临床用脂肪乳溶液  8 fatty acid microparticles clinical fat emulsion solution
9 不溶性胶体微粒 中药制剂、 多搪体 实验三、 过滤装置中滤膜支架强度实验  9 Insoluble colloidal particles Chinese medicine preparation, polysaccharides Experiment 3, filter holder strength test in filtration device
一次性使用无菌微粒截留注射器中, 其过滤装置的膜圈 (上盖和下盖组 成的滤膜支架) 附着膜片, 随注射器动作而启闭, 本实验用推拉气流检验该支 架和滤膜的强度, 观察其抗拉反复折曲承受力。  In the disposable sterile particle trapping syringe, the membrane ring of the filter device (the filter holder composed of the upper cover and the lower cover) is attached to the membrane, and is opened and closed with the action of the syringe. This experiment uses the push-pull airflow to test the stent and the filter membrane. The strength of the tensile strength of the tensile bending was observed.
方法: 采用 l〜50ml空截一次性使用无菌微粒截留注射器。 空截以最快速后 退至末端再返回顶端为一次动作, 共 10次结束。 每次动作后观察注射器内顶端 单侧挂式支架在内筒中是否移位, 再取出过滤装置置于生物显微镜下, 观察滤 膜包埋支架是否松动, 滤膜是否变形, 支架是否与注射器内顶端保持水平面, 支架插入注射器是否如初, 环形滤膜包埋边沿是否脱离, 膜圈与膜片之间滤膜 是否穿孔。  Method: A sterile microparticle-retaining syringe was used with a l~50 ml empty cut. The empty cut ends with the fastest back to the end and back to the top for an action, ending 10 times. After each movement, observe whether the top-side bracket of the syringe is displaced in the inner cylinder, and then take out the filter device under the biological microscope to observe whether the filter-embedded stent is loose, whether the filter is deformed, and whether the stent is in the top of the syringe. Maintain the horizontal plane, whether the stent is inserted into the syringe as it is, whether the enveloping edge of the annular filter is detached, and whether the filter membrane is perforated between the membrane ring and the diaphragm.
结果:  Result:
1 )、 无松动。 2 )、 不变形。 1), no looseness. 2), no deformation.
3 )、 如初。  3), as early as.
4 )、 未脱离。  4), not detached.
5 )、 未穿孔。  5), not pierced.
上述 1〜10次实验结果显示: 过滤膜片未脱落、 环形滤膜包埋边沿未脱离、 支架装置未松动、 滤膜未穿孔, 即一切如初完好无损。 本发明空截一次性使用 无菌微粒截留注射器的过滤装置无一次破损, 其强度合格。  The above 1~10 experimental results show that the filter membrane has not fallen off, the annular filter envelope is not detached, the stent device is not loose, and the filter membrane is not perforated, that is, everything is intact. The filter device of the invention for emptying and disposable sterile particle-retaining syringe has no damage at one time, and its strength is qualified.
实验四、 过滤装置中滤膜抗液体冲击破损实验  Experiment 4: Anti-liquid impact damage test of filter membrane in filter device
本实验以生理盐水来检验滤膜抗液体冲击力破损能力。  In this experiment, the ability of the membrane to resist liquid impact damage was examined by physiological saline.
方法: 采用 20ml—次性使用无菌微粒截留注射器, 一次性抽取理盐水 20ml 分为一次推出 2ml, 共 10次结束, 每次观察是否有药液渗出以及进液是否顺利, 每次推出后取出置于注射器内顶端全套侧挂式过滤装置, 置于生物显微镜下观 察是否完好无破损。  Method: Using 20ml-times sterile microparticle-retaining syringe, one-time extraction of 20ml of saline solution, divided into 2ml, one end, a total of 10 times, each time to observe whether there is liquid oozing and whether the liquid is smooth, after each launch Remove the full set of side-mounted filter devices placed in the top of the syringe and place them under a biological microscope to see if they are intact.
结果: 经上述一次 2ml推出 10次滤膜实验结果显示, 均未出现药液渗漏、 漏气, 药液过膜迅速, 且过滤膜并无穿孔破损。  RESULTS: The results of the above-mentioned 10 ml filtration test showed that there was no leakage or leakage of the drug solution, and the drug solution was quickly passed through, and the filter membrane was not damaged by perforation.
实验五、 不同规格一次性使用无菌微粒截留注射器的微粒截留  Experiment 5: Microparticle retention of sterile microparticle-retaining syringes in different specifications for single use
发明人基于上述研究, 得到系列规格的一次性使用无菌微粒截留注射器。 其 配置参见表 5。  Based on the above studies, the inventors obtained a series of disposable single-use sterile particle-retaining syringes. See Table 5 for its configuration.
表 5 —次性使用无菌微粒截留注射器 lml〜100ml规格滤膜配置表 序 注射器 圆膜直 名称 泡压 Bulb 厚度 流量 工作温度 号 规格 径  Table 5 - Secondary use of sterile microparticle-retaining syringes lml~100ml size filter configuration table Syringe Round film straight name Bubble pressure Bulb Thickness Flow Operating temperature No. Specification Diameter
1 1ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 1 1ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
2 2ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 2 2ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
3 2.5ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 3 2.5ml 4mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
4 3ml 5 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 4 3ml 5 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
5 5ml 5 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 5 5ml 5 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
6 10ml 6mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 6 10ml 6mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
7 20ml 6mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 7 20ml 6mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
8 30ml 8 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 8 30ml 8 mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
9 50ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 9 50ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
1 60ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 1 60ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
0  0
1 100ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm2 <40°C 1 100ml 10mm LMG-PES0.45 m 0.23Mpa 0.12-0.13mm 60ml/min/cm 2 <40°C
1  1
备注: 上述 1ml规格注射器胶塞需改呈直角平面, 便于滤膜整个装置的植入 采用规格: Remarks: The above 1ml specification syringe rubber plug needs to be changed to a right angle plane, which is convenient for the whole device of the filter membrane. Adopt specifications:
1.一次性使用无菌微粒截留注射器, 规格 lml〜100ml共 11个规格。  1. One-time use of sterile microparticles to retain the syringe, specifications lml ~ 100ml a total of 11 specifications.
2.一次性次性使用无菌注射针, 规格 0. 4mn!〜 1. 6mm。  2. One-time use of sterile injection needles, size 0. 4mn! ~ 1. 6mm.
3.按注射操作, 插入瓶塞模拟溶药完毕后抽药操作, 每支按注射器公称计量 抽取去离子水 (deionized water) ,取后推入 200ml量杯, 每个规格 10次, 共 110次模拟。  3. According to the injection operation, insert the cork to simulate the dissolution of the drug after the completion of the drug extraction operation, each deionized water is taken according to the nominal metering of the syringe, and then pushed into the 200ml measuring cup, each specification 10 times, a total of 110 simulations .
4.量杯液体 1次移取 10微升至生物倒直显微镜片, 分次镜下观察滤液, 结 果均无颗粒微粒显示。  4. The measuring cup liquid was transferred 10 times to the biological inverted microscope piece, and the filtrate was observed under the microscope. The results showed no particle particles.
5.取出注射器内支架及滤膜整个装置, 置于生物显微镜下观察滤膜纳污面, 镜下可见粒径 1 μ πΓ300 μ m (微米)或更大的颗粒,不溶性微粒肉眼都能识别到。 可见微粒全截留于截留注射器滤膜上表面, 说明采用一次性使用无菌微粒截留 注射器可截留上述粒径 Ι μ πκ 5 μ m, ΙΟ μ πκ 15 μ πι、 20 μ m, 50 μ m、 300 μ m 或更大颗粒, 并可以一次性彻底截留颗粒。  5. Remove the inner stent and the filter membrane from the whole device, and observe the stained surface of the filter under a biological microscope. The particles with a particle size of 1 μ πΓ300 μm (micrometer) or larger can be seen under the microscope. The insoluble particles can be recognized by the naked eye. . It can be seen that the microparticles are completely trapped on the upper surface of the trapping syringe filter, indicating that the above-mentioned particle size Ι μ πκ 5 μ m, ΙΟ μ πκ 15 μ πι, 20 μ m, 50 μ m, 300 can be intercepted by the disposable sterile particle trapping syringe. μ m or larger, and the particles can be completely removed at one time.
结论: 经上述实验结果显示本发明所提供的各规格注射器推出液中均无颗粒 微粒。  Conclusion: The above experimental results show that there is no particulate particles in the ejection liquid of each specification syringe provided by the present invention.
实验六: 本发明注射器过滤装置与输液器过滤装置原理分析  Experiment 6: Principle analysis of the syringe filter device and the infusion device filter device of the present invention
采用压力状态下的微孔滤膜微粒截留, 可实现大小颗粒微粒的一次性截留。 但输液器终末端滤膜设置属微重力 (仅依靠药液重力), 易堵塞膜孔, 除非膜孔 径与微粒粒径之间差距较大, 方能实现滤液流速流量不衰减, 但是孔径的增大 又显然减弱了微粒的截留效果。  With the microporous membrane particle trapping under pressure, a one-time retention of large and small particles can be achieved. However, the end filter of the infusion set is microgravity (only relying on the gravity of the liquid), which is easy to block the pores of the membrane. Unless the gap between the membrane pore size and the particle size is large, the flow rate of the filtrate can be prevented from attenuating, but the pore diameter is increased. Large and obviously weakened the interception effect of the particles.
在压力状态下, 如采用微孔聚醚砜滤膜 0. 45 μ πι、 直径 25mm滤膜经真空减压 滤瓶抽滤中药混浊初提液, 滤膜上表面呈现微粒全截留, 能截留大于 Ι μ πκ 5 μ πι 、 ΙΟ μ πκ 20 μ πι 、 50 μ m、 300 μ πι或更大的颗粒, 而不溶性微粒肉眼都能 识别到, 而滤出液中无颗粒微粒, 这足以说明压力截留 (或称为 "重力截留" ) 是关键。  Under pressure, such as microporous polyethersulfone filter 0. 45 μ πι, diameter 25mm filter through vacuum vacuum filter bottle suction filtration of Chinese herbal turbid liquid extract, the upper surface of the filter shows full retention of particles, can be more than cut Ι μ πκ 5 μ πι, ΙΟ μ πκ 20 μ πι, 50 μ m, 300 μππ or larger particles, insoluble particles can be recognized by the naked eye, and there are no particulate particles in the filtrate, which is enough to explain the pressure interception (or "gravity interception") is the key.
本发明一次性使用无菌微粒截留注射器其原理是采用压力推出实现过滤, 不 同于已有输液器的过滤原理。 所以本发明中滤膜孔径大小变化无明显的衰减阻 碍, 随着注量的增加, 微粒在膜表积聚量也随之增多, 堵塞部分滤膜但滤液流 量仍不出现衰减趋势。 一次性使用无菌微粒截留注射器采用聚醚砜膜(孔径 The principle of the disposable sterile particle trapping syringe of the present invention is that the filtration is carried out by pressure pushing, which is different from the filtering principle of the existing infusion set. Therefore, in the present invention, the pore size change of the membrane has no obvious attenuation hindrance, and as the fluence increases, the amount of particulate accumulation in the membrane surface also increases, and a part of the membrane is blocked, but the filtrate flow rate does not show a decay tendency. Single-use sterile microparticle-retaining syringe with polyethersulfone membrane (aperture
0. 45 μ m)。 0. 45 μ m).
以上详细介绍了本发明最佳一次性使用无菌微粒截留注射器的构成及功 用, 然而, 本发明的保护范围不应仅限于附图和实施例的形式, 例如, 采用本 发明的设计理念, 可以在一次性无菌注射器顶端设外植入过滤装置, 或在内侧 贴覆水平微型过滤装置等制作出类似产品, 这些形式的微粒截留注射器仍属于 本发明公开和保护范围。 如有人避开附图所示设置方式, 应该理解, 这种为逃 避侵权故意做出的选择仍然是对本发明的侵害 The composition and function of the optimal disposable sterile particulate retentive syringe of the present invention are described in detail above. However, the scope of protection of the present invention should not be limited to the drawings and embodiments, for example, According to the design concept of the invention, a similar product can be produced by externally implanting a filtering device at the tip of a disposable sterile syringe, or by attaching a horizontal microfiltration device to the inside. These forms of particulate trapping syringes are still within the scope of the present disclosure. If someone avoids the setting shown in the drawing, it should be understood that this intention to evade infringement is still an infringement of the present invention.

Claims

权 利 要 求 书 Claims
^ 1.一次性使用无菌微粒截留注射器, 包括外筒、 置于外筒内的推液杆和外 筒前端一侧用于装针的针座, 外筒和针座以出液口连通, 其特征在于, 还包括 一过滤装置, 该过滤装置设一过滤膜, 该过滤膜附于出液口, 且向前端封闭, 向后端开启。  ^ 1. Disposable sterile particle trapping syringe, including an outer cylinder, a push rod placed in the outer cylinder and a needle holder for loading the needle on the front end side of the outer cylinder, and the outer cylinder and the needle seat are connected by the liquid outlet. The utility model further comprises a filtering device, wherein the filtering device is provided with a filtering membrane attached to the liquid outlet, and is closed to the front end and opened to the rear end.
2.根据权利要求 1 所述一次性使用无菌微粒截留注射器, 其特征在于, 所述过 滤装置包埋在外筒最顶端前壁。  A disposable sterile particulate trapping syringe according to claim 1, wherein said filter means is embedded in a topmost front wall of the outer cylinder.
3.根据权利要求 2所述一次性使用无菌微粒截留注射器, 其特征在于, 所述过 滤装置包括一插件, 过滤膜固定在该插件中, 所述外筒最顶端前壁靠针座的一 侧沿外筒弧线方向开设与该插件匹配的装配长孔, 该插件装配于该长孔内。 The disposable aseptic particulate trapping syringe according to claim 2, wherein the filtering device comprises an insert, the filter membrane is fixed in the insert, and the outermost front wall of the outer cylinder is supported by the needle seat The side of the outer cylinder is arcuately opened to form an assembly long hole matching the insert, and the insert is fitted in the long hole.
4.根据权利要求 3所述一次性使用无菌微粒截留注射器, 其特征在于, 所述插 件包括顺序连为一体的销头、 连接片和中空的膜圈, 所述过滤膜固定在膜圈上, 连接片和膜圈在外筒之内, 销头在外筒之外。 The disposable aseptic microparticle-retaining syringe according to claim 3, wherein the insert comprises a pin head, a connecting piece and a hollow membrane ring which are integrally connected in series, and the filter membrane is fixed on the membrane ring. , the connecting piece and the membrane ring are inside the outer cylinder, and the pin head is outside the outer cylinder.
5.根据权利要求 1或 2或 3或 4所述一次性使用无菌微粒截留注射器, 其特征 在于, 所述过滤膜被固定在一组对扣的上盖和下盖之间形成膜片, 过滤膜以该 膜片的形式被装配。  The disposable aseptic microparticle-retaining syringe according to claim 1 or 2 or 3 or 4, wherein the filter membrane is fixed between a top cover and a lower cover of a pair of buckles to form a diaphragm. The filter membrane is assembled in the form of the membrane.
6.根据权利要求 5所述一次性使用无菌微粒截留注射器, 其特征在于, 所述上 盖和下盖为圈体, 圈体的中空部分设有用以托衬过滤膜的网格, 上盖和下盖的 圈体实体部分分别设对位固定的凹痕和凸起。  The disposable aseptic microparticle-retaining syringe according to claim 5, wherein the upper cover and the lower cover are ring bodies, and the hollow portion of the ring body is provided with a mesh for lining the filter membrane, and the upper cover And the solid part of the ring body of the lower cover are respectively provided with indented fixed protrusions and protrusions.
7.根据权利要求 5或 6所述一次性使用无菌微粒截留注射器, 其特征在于, 所 述外筒最顶端前壁内侧对应膜片位置开设定位凹槽, 且该定位凹槽尺寸大于膜 片边沿尺寸 0. 05腿。  The disposable aseptic microparticle-retaining syringe according to claim 5 or 6, wherein the inner side of the outermost front wall of the outer cylinder has a positioning groove corresponding to the position of the diaphragm, and the positioning groove has a size larger than the diaphragm. Edge size 0. 05 legs.
8.根据权利要求 7所述一次性使用无菌微粒截留注射器, 其特征在于, 所述外 筒最顶端前壁加厚至 4mm。 8. A single use sterile particulate retention syringe according to claim 7, wherein the outermost front wall of the outer cylinder is thickened to 4 mm.
9.根据权利要求 8所述一次性使用无菌微粒截留注射器, 其特征在于, 所述外 筒前端在装有膜片的一侧为增厚至 2mm的半圆锥形受力侧壁。 The disposable aseptic particulate trapping syringe according to claim 8, wherein the front end of the outer cylinder is a semi-conical force-receiving side wall thickened to 2 mm on the side on which the diaphragm is attached.
10.根据权利要求 9所述一次性使用无菌微粒截留注射器, 其特征在于, 所述膜 片的上盖厚 0. 15mm, 下盖厚 0. 05mm, 过滤膜厚 0. 11-0. 12mm; 所述插件的销头 厚 12mm, 连接片厚度 0. 32mm, 膜圈厚 0. 35匪; 所述销头的弧线长度大于外筒装 配长孔的弧线长度。  0. 12mm. The thickness of the filter film is 0. 05mm, the thickness of the filter film is 0. 11-0. 12mm The insertion head has a thickness of 12 mm, the thickness of the connecting piece is 0.332 mm, and the thickness of the film ring is 0.35 匪; the length of the arc of the pin head is larger than the length of the arc of the long hole of the outer tube assembly.
PCT/CN2013/076271 2012-06-07 2013-05-27 Disposable sterile injector for retaining microparticles WO2013182000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210185950.7 2012-06-07
CN201210185950.7A CN102671262B (en) 2012-06-07 2012-06-07 Disposable sterile particulate-retaining syringe

Publications (1)

Publication Number Publication Date
WO2013182000A1 true WO2013182000A1 (en) 2013-12-12

Family

ID=46804240

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/076271 WO2013182000A1 (en) 2012-06-07 2013-05-27 Disposable sterile injector for retaining microparticles

Country Status (2)

Country Link
CN (1) CN102671262B (en)
WO (1) WO2013182000A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102671262B (en) * 2012-06-07 2014-04-16 中山未标生物新技术有限公司 Disposable sterile particulate-retaining syringe
CN108434551B (en) * 2018-04-13 2021-05-14 山东中医药大学 Dropper with injection filtering function
CN112277333A (en) * 2019-07-25 2021-01-29 江苏正迈过滤技术有限公司 Medical filter and production method thereof
CN113350619A (en) * 2021-07-08 2021-09-07 上海振浦医疗设备有限公司 Built-in membrane filtering injector

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1363128A (en) * 1920-02-11 1920-12-21 Shigezo Nishitani Injection-syringe
US4137917A (en) * 1977-05-12 1979-02-06 Cohen Milton J Syringe filter unit
CN101648040A (en) * 2009-09-04 2010-02-17 上海一童医疗用品有限公司 Disposable precise filtering injector
CN201612904U (en) * 2010-02-27 2010-10-27 孙风林 Syringe with filter function
CN102406971A (en) * 2011-12-29 2012-04-11 雷红力 Filter type syringe
CN102671262A (en) * 2012-06-07 2012-09-19 杨昌燕 Disposable sterile particulate-retaining syringe
CN202666105U (en) * 2012-06-07 2013-01-16 杨昌燕 Disposable aseptic particle entrapment injector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN200998481Y (en) * 2006-07-31 2008-01-02 王哲兴 Disposable sterile filtering type syringe
CN201959347U (en) * 2011-01-25 2011-09-07 上海振浦医疗设备有限公司 Disposable precise filter injector

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1363128A (en) * 1920-02-11 1920-12-21 Shigezo Nishitani Injection-syringe
US4137917A (en) * 1977-05-12 1979-02-06 Cohen Milton J Syringe filter unit
CN101648040A (en) * 2009-09-04 2010-02-17 上海一童医疗用品有限公司 Disposable precise filtering injector
CN201612904U (en) * 2010-02-27 2010-10-27 孙风林 Syringe with filter function
CN102406971A (en) * 2011-12-29 2012-04-11 雷红力 Filter type syringe
CN102671262A (en) * 2012-06-07 2012-09-19 杨昌燕 Disposable sterile particulate-retaining syringe
CN202666105U (en) * 2012-06-07 2013-01-16 杨昌燕 Disposable aseptic particle entrapment injector

Also Published As

Publication number Publication date
CN102671262B (en) 2014-04-16
CN102671262A (en) 2012-09-19

Similar Documents

Publication Publication Date Title
WO2013182000A1 (en) Disposable sterile injector for retaining microparticles
CN105832547B (en) Bi-directional filtered dispensation injection needle
CN204734799U (en) Needleless infusion prevents that needle is kept somewhere to vein against current
CN202666105U (en) Disposable aseptic particle entrapment injector
CN105853227B (en) Unidirectional filtering safe type dispensation injection needle
CN201814857U (en) Liquor dispensing device
CN105919805B (en) Dispensation injection needle with bi-directional filtered function
CN105832546B (en) Safety-type dispensation injection needle with unidirectional filtering function
CN204446799U (en) Medical safe Mo Feishi dropper
CN202637637U (en) Macromolecule ultra-filter for transfusion
CN208405371U (en) Dispenser
CN105919806B (en) Dispensation injection needle with unidirectional filtering function
CN208492831U (en) Automatic exhaust, only liquid, accurate filter device
CN204655676U (en) A kind of syringe
CN206102975U (en) Two -way filtration of safe type syringe needle that dispenses
CN204932267U (en) The accurate molten medicine entry needle of single use
CN208958788U (en) A kind of quick dispensing needle of anti-exfoliation
CN209220298U (en) Spring back telescopic type safe blood-taking needle
CN208660034U (en) Static pressure exhaust, tension stop liquid lucifugal infusion device
CN213312406U (en) Disposable automatic exhaust and liquid-stop infusion apparatus
CN209378170U (en) Disposable Radiotherapy chemotherapy infusion apparatus
CN201283136Y (en) Disposable fine-filtering infusion device
CN209611757U (en) Disposable efficient medical liquid dispenser
CN202218996U (en) Blood-return preventing infusion tube set
CN207679793U (en) A kind of clinical care intravenous transfusion device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13800152

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13800152

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 13/02/2015)

122 Ep: pct application non-entry in european phase

Ref document number: 13800152

Country of ref document: EP

Kind code of ref document: A1